New cellular therapy offers hope for multiple myeloma patients
UChicago Medicine is the first program in Chicago to offer Abecma, a cell-based gene therapy for patients with treatment-resistant multiple myeloma.
Cancer and COVID-19: the impact of missed screenings in vulnerable communities
The COVID-19 pandemic has led to steep declines in cancer screenings, particularly in underserved communities, which have led to decreased diagnoses and could result in thousands of deaths, worsening cancer disparities.
Novel biomarker predicts how non-small cell lung cancer will progress after immunotherapy
Researchers identified a novel biomarker for predicting the progression of non-small cell lung cancer after immunotherapy.
